BeOne Medicines (ONC) Gross Profit (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.70% |
| Dec 31, 2025 | 11.51% |
| Sep 30, 2025 | 5.66% |
| Jun 30, 2025 | 20.84% |
| Mar 31, 2025 | -1.55% |
| Dec 31, 2024 | 16.38% |
| Sep 30, 2024 | 5.07% |
| Jun 30, 2024 | 26.22% |
| Mar 31, 2024 | 18.57% |
| Dec 31, 2023 | -22.84% |
| Sep 30, 2023 | 37.20% |
| Jun 30, 2023 | 36.41% |
| Mar 31, 2023 | 19.39% |
| Dec 31, 2022 | -1.45% |
| Sep 30, 2022 | 15.05% |
| Jun 30, 2022 | 12.02% |
| Mar 31, 2022 | 45.91% |
| Dec 31, 2021 | 4.03% |
| Sep 30, 2021 | 39.83% |
| Jun 30, 2021 | -80.16% |
| Mar 31, 2021 | 625.35% |
| Dec 31, 2020 | 12.96% |
| Sep 30, 2020 | 36.29% |
| Jun 30, 2020 | 35.39% |
| Mar 31, 2020 | -2.57% |
| Dec 31, 2019 | 29.54% |
| Sep 30, 2019 | -77.27% |
| Jun 30, 2019 | 111.21% |
| Mar 31, 2019 | 26.47% |
| Dec 31, 2018 | 8.75% |
| Sep 30, 2018 | -2.26% |
| Jun 30, 2018 | 66.28% |
| Mar 31, 2018 | 84.85% |
| Dec 31, 2017 | -93.06% |